On ECHEMI
Home > Drugs > Cerebral palsy
Cerebral palsy
Cerebral palsy, also known as infantile cerebral palsy, is a clinical syndrome of congenital motor dysfunction and abnormal posture. The symposium on cerebral palsy in my country (1988) proposed the definition of cerebral palsy as: a syndrome of non-progressive brain damage in the developmental period from before birth to one month after birth, mainly manifested as central motor disorders and abnormal posture. Transient motor disorders, progressive brain diseases and spinal cord lesions caused by other reasons are not within the scope of this disease.
  • Site of disease:

    Brain
  • Infectious :

    Not contagious
  • Frequent population:

    Newborns
  • Related symptoms:

    Irritability fatigue long-term illness loss slow reaction weight gain
  • Concurrent disease:

Related Drugs
2D Sanqi Cinnarizine Capsules
Indication: Used for ischemic cerebrovascular disease and its sequelae.
Manufacturer:

Livzon (GROUP) Pharmaceutical FACTORY

Baclofen Tablets
Indication: This product is used to relieve skeletal muscle spasms caused by the following diseases: 1. Multiple sclerosis, syringomyelia, spinal cord tumors, transverse myelitis, spinal cord trauma and motor neuron disease. 2. Cerebrovascular disease, cerebral palsy, meningitis, craniocerebral trauma.
Manufacturer:

Yunnan Mingding Pharmaceutical Co., Ltd.

Myo-aminopeptide injection
Indication: Paralysis caused by cerebrovascular accident; muscle atrophy caused by peripheral nervous system diseases; neurasthenia syndrome, etc.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.